Make Diabetes a Smaller Part of Life With Omnipod® 5
Omnipod 5: Now Available in Canada*
Fuel your freedom with the tubeless, waterproof† Omnipod 5 Automated Insulin Delivery System.
Forget multiple daily injections, insulin pump tubing and routine fingerstick testing‡, and discover simplified diabetes management that can help you to live your life, your way.
For requests to use video content please contact:
Stephanie Libous
Director of Public Relations
[email protected]
3 simple parts
Controller + Pod + Sensor
The first and only tubeless automated insulin delivery system that works with Dexcom G6 and G7
Omnipod 5 is the first wearable, tubeless, hybrid closed loop insulin delivery system to integrate with Dexcom G6 and G7 sensors.§
Omnipod 5 automatically adjusts insulin delivery every 5 minutes, helping to protect against highs and lows.1,2
This means the convenience and simplicity of Pod Therapy is now available for people wearing a compatible sensor who are looking for an automated insulin delivery system.
What is Pod Therapy?
Description automatically generatedPod Therapy is simple, tubeless, discreet insulin pump therapy for people living with type 1 diabetes, ages 2 and older.
Each wearable Pod continuously delivers personalized doses of insulin for up to three days (72 hours), controlled wirelessly by you, wherever you are.
With no multiple daily injections and no tubes, Pod Therapy is insulin pump therapy, simplified. Only found with Omnipod.
Meet our tubeless, wearable Omnipod lineup
Omnipod 5 Automated Insulin Delivery System
Now available!* Omnipod 5 is integrated with Dexcom G6 and G7 sensors to automatically adjust your insulin every five minutes, helping to stay in range throughout the day and night.1,2
Omnipod DASH® Insulin Management System
You’re in control with Omnipod DASH Discover discreet, precise insulin dosing and customisable programmes designed to fit around your lifestyle.
We believe in freedom of choice!
At Insulet, we believe people who are eligible for pump therapy should have the freedom to choose and the flexibility to change insulin delivery devices. Pod Therapy offers a tubeless, waterproof alternative to pump therapy.
Are you new to pump therapy, or considering switching to a different insulin pump? Find out more about how our commitment to choice may help you.
Here’s what our Podders have to say about Omnipod …
Omnipod 5 has allowed me to get a good night sleep. That's the first time I can say that in a long time.
Alvin
Podder since 2017
It helps me feel like a normal kid, just with a little bit of help.
Romey T.
Sponsored Omnipod® User
& Podder since 2019
I don’t have to spend as much time thinking about diabetes.
Clare F.
Podder® since 2013
Try it on for size
Request a free Pod Experience Kit (PEK) today and try a demo Pod¶ for yourself!
Whether you’re considering Omnipod 5 or Omnipod DASH, our real-size, real-weight demo Pod¶ can help you understand what it feels like to wear the Pod and get a sense of how discreet it can be.
*Coverage varies by province. Check your provincial guidelines for any restrictions.
†The Pod has an IP28 rating for up to 7.6 metres (25 feet) for up to 60 minutes. The Omnipod 5 Controller and the Omnipod DASH PDM are not waterproof. Please consult sensor manufacturer user guide for sensor waterproof rating.
‡Routine fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
§Compatible with the Dexcom G6 and Decom G7 Sensors. Sensor is required for Automated Mode. Boluses for meals and corrections are still necessary. Sensors are sold separately and require a separate prescription. The Dexcom Sensors must be used with the Dexcom mobile app. The Dexcom receiver is not compatible. Devices compatible with Dexcom apps can be found at dexcom.com/compatibility.
¶The PEK includes a non-functioning, needle-free Pod which allows you to experience how it feels to wear a Pod. The demo Pod is for demonstrative purposes only and is not able to deliver insulin. This PEK is available only to people with type 1 diabetes who are on current insulin treatment (e.g., multiple daily injections or insulin pump therapy). People with type 2 diabetes are not eligible to receive a PEK unless they reside in British Columbia. The PEK does not include a physical Omnipod 5 Controller or the Omnipod DASH PDM.
1. Brown SA, et al. Diabetes Care. 2021;44(7):1630-1640. Prospective pivotal trial in 240 participants with T1D aged 6-70 yrs [adults/adolescents (n=128; aged 14-70 yrs) children (n=112; aged 6-13.9 yrs)]. Study included a 14-day standard therapy (ST) phase followed by a 3-month Omnipod 5 hybrid closed-loop phase. Mean time >180 mg/dL or >10 mmol/L in adults/adolescents and children, ST vs. 3-mo Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%, p<0.0001, respectively. Mean time <70 mg/dL or <3.9 mmol/L in adults/adolescents and children, ST vs. 3-mo Omnipod 5: 2.9% vs. 1.3%, p<0.0001; 2.2% vs. 1.8%, p=0.8153, respectively. Results measured by CGM.
2. Sherr JL, et al. Diabetes Care. 2022;45(8):1907-1910. Prospective trial in 80 participants with T1D aged 2-5.9 yrs. Study included a 14-day standard therapy (ST) phase followed by a 3-month Omnipod 5 hybrid closed-loop (HCL) phase. Mean time >180 mg/dL or >10 mmol/L in very young children (2-5.9 yrs) as measured by CGM: ST = 39.4%, 3-mo Omnipod 5 = 29.5%, p<0.0001. Mean time <70 mg/dL or <3.9 mmol/L in very young children (2-5.9 yrs) as measured by CGM: ST = 3.43%, 3-mo Omnipod 5 = 2.46%, p=0.0204. Results measured by CGM.
